Skip to content

Study on the Application of Auricular Point Sticking Combined with Standardized Nursing in Alleviating Herpes Zoster Pain

Study on the Application of Auricular Point Sticking Combined with Standardized Nursing in Alleviating Herpes Zoster Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001262
Enrollment
Unknown
Registered
2026-05-18
Start date
2026-05-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shingles

Interventions

Observation group:Standardized nursing + auricular sticking (adrenal, shenmen, ear apex points
biweekly replacement for 1 month)
Control Group:Standardized nursing (environmental care, skin care, dietary guidance, health education for 1 month)

Sponsors

General Hospital of Southern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 69 Years

Inclusion criteria

Inclusion criteria: (1) Meet diagnostic criteria from "Herpes Zoster Diagnosis and Treatment Guidelines (2018)" (2) Age 18-70 years (3) No pre-admission antiviral/analgesic use (4) VAS score >6 (5) Treatment compliance (6) Conscious and cooperative (7) Signed informed consent

Exclusion criteria

Exclusion criteria: (1) Patients with severe concurrent renal or hepatic dysfunction (2) Local auricular skin conditions: individuals with localized auricular infection, erosion, eczema, or other dermatological disorders precluding auricular acupressure application, as well as those with hypersensitivity to adhesive tape or Vaccaria segetalis seeds (3) Patients with psychiatric disorders who are unable to comply with treatment protocols (4) Prior history of auricular therapy: subjects who have undergone auricular acupressure, auricular acupuncture, or related interventions within the preceding 3 months (5) Concomitant use of other analgesic modalities: individuals receiving treatments that may confound pain assessment, including nerve block procedures, targeted physical therapy, or participation in other pharmaceutical clinical trials (6) Pregnancy or lactation period (7) Patients with concurrent malignant tumors, autoimmune diseases, or other severe chronic conditions (8) Individuals unable to adhere to follow-up schedules or with incomplete clinical documentation

Design outcomes

Primary

MeasureTime frame
Pain Level;Herpes resolution time;Crust formation time;Lesion disappearance time;

Secondary

MeasureTime frame
Sleep quality;Self-efficacy;Anxiety;Depressive Mood;

Countries

China

Contacts

Public ContactCao Lu

Dermatology Department, General Hospital of Southern Theater Command

caolu1983@126.com13560375708

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026